Comment: Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients.
Vandijck
Dominique M
DM
Blot
Stijn I
SI
Decruyenaere
Johan M
JM
D000935:Antifungal Agents / Q000191:economics / Q000627:therapeutic use*; D002175:Candida / Q000145:classification* / Q000302:isolation & purification; D002176:Candida albicans; D002177:Candidiasis / Q000191:economics / Q000453:epidemiology / Q000382:microbiology*; D006801:Humans; D015994:Incidence; D007902:Length of Stay; D012307:Risk Factors; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
D000935:Antifungal Agents